abstract |
The use of an estrogen agonist for the manufacture of a medicament for thentreatment or prevention of osteoporosis, cardiovascular disease or breast cancer in anhuman patient under treatment with warfarin or propranolol without interfering withnthe action of said warfarin or propranolol. |